Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus ...
3h
Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback